| Literature DB >> 30734012 |
E Gammeri1, T Petrinic2, G Bond-Smith1, A Gordon-Weeks1,3.
Abstract
Background: The use of peritoneal lavage to prevent postoperative intra-abdominal abscess (IAA) after appendicectomy has been debated widely.Entities:
Mesh:
Year: 2018 PMID: 30734012 PMCID: PMC6354188 DOI: 10.1002/bjs5.50118
Source DB: PubMed Journal: BJS Open ISSN: 2474-9842
Figure 1PRISMA diagram for the review
Figure 2Forest plots of postoperative intra‐abdominal abscess, wound infection, duration of surgery and length of hospital stay. a Intra‐abdominal abscess (IAA), b wound infection (WI), c duration of surgery, d length of hospital stay. a,b Mantel–Haenszel and c,d inverse variance random‐effects models were used for meta‐analysis. a,b Risk differences and c,d mean differences are shown with 95 per cent confidence intervals.
Quality assessment of controlled intervention, observational cohort and cross‐sectional studies
| Sun | Snow | Cho | Hartwich | St Peter | Moore | Toki | Stewart and Matheson | |
|---|---|---|---|---|---|---|---|---|
| 1. Was the research question or objective in this paper clearly stated? | Yes | Yes | Yes | Yes | Yes | ? | Yes | Yes |
| 2. Was the study population clearly specified and defined? | Yes | Yes | Yes | Yes | Yes | ? | Yes | Yes |
| 3. Was the participation rate of eligible persons at least 50%? | Yes | Yes | Yes | Yes | Yes | ? | Yes | Yes |
| 4. Were all the subjects selected or recruited from the same or similar populations? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | Yes | Yes | Yes | Yes | Yes | ? | Yes | Yes |
| 5. Study described as randomized? | Yes | Yes | No | No | Yes | No | No | No |
| 6. Randomization method adequate? | Yes | Yes | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 7. Was the treatment allocation concealed (so that assignments could not be predicted)? | No | No | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 8. Were study participants and providers blinded to treatment group assignment? | No | No | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 9. Were the people assessing the outcomes blinded to the participants' group assignments? | No | No | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 10. Were the groups similar at baseline on important characteristics that could affect outcomes (e.g. demographics, risk factors, co‐morbid conditions)? | Yes | Yes | n.a. | n.a. | No | ? | n.a. | n.a. |
| 11. Was the overall dropout rate from the study at endpoint 20% or lower than the number allocated to treatment? | Yes | Yes | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 12. Was the differential dropout rate (between treatment groups) at endpoint 15% or less? | Yes | Yes | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 13. Was there high adherence to the intervention protocols for each treatment group? | Yes | Yes | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 14. Were other interventions avoided or similar in the groups (e.g. similar background treatments)? | No | No | n.a. | n.a. | Yes | ? | n.a. | n.a. |
| 15. Were the outcome measures (dependent variables) clearly defined, valid, reliable and implemented consistently across all study participants? | Yes | Yes | Yes | Yes | Yes | ? | Yes | Yes |
| 16. Were the outcome assessors blinded to the exposure status of participants? | No | No | No | No | No | ? | No | No |
| 17. Was loss to follow‐up after baseline 20% or less? | Yes | Yes | Yes | Yes | Yes | ? | Yes | n.a. |
n.a., Not available.